KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 114 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $442,386 | +27.7% | 113,724 | +11.6% | 0.00% | 0.0% |
| Q4 2022 | $346,518 | -19.2% | 101,917 | +29.6% | 0.00% | 0.0% |
| Q3 2022 | $429,000 | +410.7% | 78,657 | +321.1% | 0.00% | – |
| Q2 2022 | $84,000 | -39.1% | 18,680 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $138,000 | -50.9% | 18,680 | +27.9% | 0.00% | -50.0% |
| Q1 2020 | $281,000 | +20.6% | 14,610 | +20.4% | 0.00% | +100.0% |
| Q4 2019 | $233,000 | -63.9% | 12,130 | -82.4% | 0.00% | -75.0% |
| Q4 2018 | $645,000 | -5.6% | 68,835 | +71.7% | 0.00% | 0.0% |
| Q3 2018 | $683,000 | +21.1% | 40,090 | +20.9% | 0.00% | +33.3% |
| Q2 2018 | $564,000 | – | 33,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
| Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
| Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
| Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
| Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
| Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
| Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
| Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
| Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |